Craig H. Mermel
Nature · 2008–2022
A researcher in the Science corpus: 17 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Craig H. Mermel trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Craig H. Mermel overall
Papers from Craig H. Mermel's perspective
Ordered by how strongly the researchers Craig H. Mermel trusts endorse each paper. Same corpus, a different order for every researcher.
- The cancer genome (Nature)
- Malignant astrocytic glioma: genetics, biology, and paths to treatment. (Genes & Development)
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments (Statistical Applications in Genetics and Molecular Biology)
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
- In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state (Nature)
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors (Nature Genetics)
- Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (New England Journal of Medicine)
- The hallmarks of cancer (RNA Biology)
- Mutational Processes Molding the Genomes of 21 Breast Cancers (Cell)
- Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing (Nature Biotechnology)
Their papers
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers (2011) — 3,145 citations
- Discovery and saturation analysis of cancer genes across 21 tumor types (2014) — 2,932 citations
- Mutational heterogeneity in cancer and the search for new cancer genes (2013) — 1,147 citations
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (2009) — 3,376 citations
- Integrated Genomic Analyses of Ovarian Carcinoma (2011) — 7,559 citations
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) — 7,050 citations
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activity (2008) — 705 citations
- SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas (2009) — 956 citations
- Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. (2012) — 595 citations
- Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge (2022) — 592 citations
- Similar image search for histopathology: SMILY (2019) — 154 citations
- Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer (2018) — 458 citations
- Age-related clonal hematopoiesis associated with adverse outcomes. (2014) — 4,169 citations
- Pan-cancer patterns of somatic copy-number alteration (2013) — 1,779 citations
- The landscape of somatic copy-number alteration across human cancers (2010) — 3,892 citations
- Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy (2010) — 718 citations
- EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer (2008) — 1,002 citations